Guangzhou Forrad Pharmaceutical Technology

Guangzhou Forrad Pharmaceutical Technology is a clinical-stage biopharmaceutical company specializing in the development of complex injectable formulations and long-acting sustained-release medications. The company leverages its proprietary microsphere and liposome technology platforms to improve the therapeutic profile of established drugs in areas such as psychiatry, endocrinology, and oncology. Its lead candidates include long-acting microsphere formulations of risperidone and octreotide, aimed at enhancing patient compliance and reducing dosing frequency. Forrad operates a full-scale R&D and manufacturing facility in Guangzhou Science City, adhering to international GMP standards to support its internal pipeline and potential CDMO partnerships.